Answer
Women planning pregnancy should discontinue cabergoline (Dostinex) one month before intended conception because of its long half-life and limited data on in utero exposure.
Sources for this answer
- Dostinex TabletsPfizer Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 16Document updated
Sources checked